Gene Symbol | Gene ID | Gene Info |
---|---|---|
TAL1
|
ENSG00000162367.7 | TAL bHLH transcription factor 1, erythroid differentiation factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_47697283_47697768 | TAL1 | 138 | 0.950011 | -0.67 | 4.7e-02 | Click! |
chr1_47697120_47697271 | TAL1 | 192 | 0.930102 | -0.47 | 2.0e-01 | Click! |
chr1_47693526_47693677 | TAL1 | 1842 | 0.258034 | 0.33 | 3.9e-01 | Click! |
chr1_47696290_47696441 | TAL1 | 922 | 0.513589 | -0.32 | 4.0e-01 | Click! |
chr1_47698056_47698349 | TAL1 | 815 | 0.569264 | -0.29 | 4.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_27301899_27302732 | 2.88 |
EMILIN1 |
elastin microfibril interfacer 1 |
880 |
0.32 |
chr2_74666737_74667617 | 2.32 |
RTKN |
rhotekin |
533 |
0.54 |
chr13_24007498_24007984 | 2.25 |
SACS |
spastic ataxia of Charlevoix-Saguenay (sacsin) |
100 |
0.98 |
chr2_191044944_191045899 | 2.11 |
C2orf88 |
chromosome 2 open reading frame 88 |
168 |
0.96 |
chrX_38079311_38080259 | 1.99 |
SRPX |
sushi-repeat containing protein, X-linked |
367 |
0.75 |
chr16_3162631_3163041 | 1.95 |
ZNF205 |
zinc finger protein 205 |
40 |
0.8 |
chr2_158113918_158114875 | 1.93 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
286 |
0.93 |
chr9_129884150_129884930 | 1.93 |
ANGPTL2 |
angiopoietin-like 2 |
373 |
0.9 |
chr2_33359781_33360142 | 1.83 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
237 |
0.96 |
chr3_157260663_157261197 | 1.80 |
C3orf55 |
chromosome 3 open reading frame 55 |
105 |
0.98 |
chrX_53349448_53350467 | 1.71 |
IQSEC2 |
IQ motif and Sec7 domain 2 |
565 |
0.73 |
chr7_37960238_37961117 | 1.69 |
EPDR1 |
ependymin related 1 |
245 |
0.94 |
chr12_71003154_71004126 | 1.64 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
16 |
0.99 |
chr12_26348638_26349346 | 1.62 |
SSPN |
sarcospan |
386 |
0.88 |
chr4_134072879_134073697 | 1.55 |
PCDH10 |
protocadherin 10 |
2818 |
0.44 |
chr5_115298168_115298999 | 1.55 |
AQPEP |
Aminopeptidase Q |
392 |
0.86 |
chr22_38476844_38477780 | 1.52 |
SLC16A8 |
solute carrier family 16 (monocarboxylate transporter), member 8 |
1837 |
0.22 |
chr18_56245541_56245920 | 1.51 |
RP11-126O1.2 |
|
21428 |
0.14 |
chr2_219646650_219647418 | 1.51 |
CYP27A1 |
cytochrome P450, family 27, subfamily A, polypeptide 1 |
555 |
0.7 |
chr2_160918347_160919586 | 1.49 |
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
155 |
0.98 |
chr1_170633420_170634117 | 1.46 |
PRRX1 |
paired related homeobox 1 |
690 |
0.8 |
chr12_53443889_53444561 | 1.45 |
TENC1 |
tensin like C1 domain containing phosphatase (tensin 2) |
255 |
0.86 |
chr1_152080538_152081099 | 1.44 |
TCHH |
trichohyalin |
5738 |
0.15 |
chr18_12278735_12279189 | 1.43 |
CIDEA |
cell death-inducing DFFA-like effector a |
24644 |
0.15 |
chr14_101292536_101293492 | 1.43 |
AL117190.2 |
|
2523 |
0.08 |
chr4_71570546_71572213 | 1.41 |
RUFY3 |
RUN and FYVE domain containing 3 |
861 |
0.36 |
chr9_134165447_134165667 | 1.41 |
PPAPDC3 |
phosphatidic acid phosphatase type 2 domain containing 3 |
358 |
0.87 |
chr19_3606102_3607092 | 1.38 |
TBXA2R |
thromboxane A2 receptor |
61 |
0.89 |
chr10_101088892_101089952 | 1.37 |
CNNM1 |
cyclin M1 |
266 |
0.95 |
chr9_104248314_104249564 | 1.35 |
TMEM246 |
transmembrane protein 246 |
460 |
0.79 |
chr17_32582682_32583141 | 1.35 |
AC005549.3 |
Uncharacterized protein |
605 |
0.41 |
chr18_499765_500605 | 1.34 |
COLEC12 |
collectin sub-family member 12 |
537 |
0.79 |
chr20_49307514_49308405 | 1.31 |
FAM65C |
family with sequence similarity 65, member C |
43 |
0.97 |
chr5_149535028_149535202 | 1.30 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
75 |
0.96 |
chr1_156645683_156645995 | 1.30 |
NES |
nestin |
1350 |
0.25 |
chr11_7599067_7599755 | 1.29 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
1140 |
0.49 |
chr12_56075239_56075869 | 1.28 |
METTL7B |
methyltransferase like 7B |
224 |
0.86 |
chr15_64231749_64232239 | 1.28 |
RP11-111E14.1 |
|
11521 |
0.22 |
chr15_39873424_39874712 | 1.28 |
THBS1 |
thrombospondin 1 |
774 |
0.66 |
chr13_96296247_96296898 | 1.28 |
DZIP1 |
DAZ interacting zinc finger protein 1 |
372 |
0.89 |
chr22_41633466_41634617 | 1.26 |
CHADL |
chondroadherin-like |
1584 |
0.26 |
chr19_45655667_45657201 | 1.25 |
NKPD1 |
NTPase, KAP family P-loop domain containing 1 |
594 |
0.58 |
chr11_114169173_114169324 | 1.24 |
NNMT |
nicotinamide N-methyltransferase |
375 |
0.89 |
chr3_8809480_8810320 | 1.24 |
OXTR |
oxytocin receptor |
463 |
0.76 |
chr6_19838575_19839711 | 1.24 |
RP1-167F1.2 |
|
168 |
0.95 |
chr11_67777777_67778022 | 1.23 |
ALDH3B1 |
aldehyde dehydrogenase 3 family, member B1 |
109 |
0.94 |
chr16_83848003_83848154 | 1.22 |
HSBP1 |
heat shock factor binding protein 1 |
6484 |
0.17 |
chr4_71479096_71479386 | 1.21 |
ENAM |
enamelin |
15220 |
0.15 |
chr5_113697124_113698006 | 1.21 |
KCNN2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
451 |
0.9 |
chr21_47401799_47402727 | 1.21 |
COL6A1 |
collagen, type VI, alpha 1 |
612 |
0.75 |
chr14_24837426_24838101 | 1.20 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
216 |
0.85 |
chr12_72665374_72665945 | 1.20 |
ENSG00000236333 |
. |
112 |
0.93 |
chr11_85396326_85396540 | 1.19 |
CCDC89 |
coiled-coil domain containing 89 |
887 |
0.51 |
chr8_97172057_97172969 | 1.18 |
GDF6 |
growth differentiation factor 6 |
507 |
0.84 |
chr1_180881914_180882730 | 1.17 |
KIAA1614 |
KIAA1614 |
3 |
0.98 |
chr18_55469401_55470160 | 1.15 |
ATP8B1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
547 |
0.82 |
chr4_16898850_16899082 | 1.15 |
LDB2 |
LIM domain binding 2 |
1219 |
0.65 |
chrX_19688369_19688923 | 1.14 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
166 |
0.97 |
chr6_46458824_46459774 | 1.13 |
RCAN2 |
regulator of calcineurin 2 |
200 |
0.78 |
chr15_48937037_48938293 | 1.13 |
FBN1 |
fibrillin 1 |
253 |
0.95 |
chr15_23931247_23932124 | 1.12 |
NDN |
necdin, melanoma antigen (MAGE) family member |
765 |
0.7 |
chr15_40530958_40531718 | 1.12 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
46 |
0.96 |
chr2_5833762_5834449 | 1.12 |
SOX11 |
SRY (sex determining region Y)-box 11 |
1306 |
0.4 |
chr5_83680091_83680703 | 1.12 |
CTD-2269F5.1 |
|
23 |
0.71 |
chr14_69657871_69659182 | 1.12 |
EXD2 |
exonuclease 3'-5' domain containing 2 |
3 |
0.98 |
chr16_84261621_84261868 | 1.11 |
KCNG4 |
potassium voltage-gated channel, subfamily G, member 4 |
11560 |
0.12 |
chr14_75747963_75748114 | 1.10 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
1142 |
0.45 |
chr6_136359084_136359592 | 1.10 |
RP13-143G15.3 |
|
26438 |
0.21 |
chr5_38445912_38446355 | 1.10 |
EGFLAM |
EGF-like, fibronectin type III and laminin G domains |
435 |
0.81 |
chr11_65639318_65639911 | 1.09 |
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
511 |
0.56 |
chr3_184504176_184504876 | 1.09 |
VPS8 |
vacuolar protein sorting 8 homolog (S. cerevisiae) |
25405 |
0.22 |
chr7_101688653_101689251 | 1.09 |
CTA-357J21.1 |
|
12649 |
0.24 |
chr12_117036919_117037510 | 1.08 |
MAP1LC3B2 |
microtubule-associated protein 1 light chain 3 beta 2 |
23558 |
0.24 |
chr3_106059964_106060303 | 1.08 |
ENSG00000200610 |
. |
174611 |
0.04 |
chr3_50395480_50396917 | 1.08 |
TMEM115 |
transmembrane protein 115 |
843 |
0.33 |
chr13_110958781_110959436 | 1.08 |
COL4A1 |
collagen, type IV, alpha 1 |
370 |
0.6 |
chr17_48287259_48287746 | 1.07 |
COL1A1 |
collagen, type I, alpha 1 |
8509 |
0.12 |
chr17_67498077_67498704 | 1.07 |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
17 |
0.99 |
chr1_109940210_109941121 | 1.07 |
SORT1 |
sortilin 1 |
92 |
0.96 |
chr17_38498589_38499681 | 1.06 |
CTD-2267D19.2 |
|
253 |
0.69 |
chr7_128471351_128471889 | 1.05 |
FLNC |
filamin C, gamma |
1140 |
0.39 |
chr9_139481472_139481814 | 1.05 |
ENSG00000252440 |
. |
15324 |
0.1 |
chr19_9473504_9474272 | 1.05 |
ZNF177 |
zinc finger protein 177 |
181 |
0.93 |
chr5_78203584_78204130 | 1.04 |
ARSB |
arylsulfatase B |
77751 |
0.11 |
chr2_1734975_1735274 | 1.04 |
PXDN |
peroxidasin homolog (Drosophila) |
13090 |
0.27 |
chr7_15725092_15725754 | 1.04 |
MEOX2 |
mesenchyme homeobox 2 |
1014 |
0.63 |
chr3_147128128_147129466 | 1.04 |
ZIC1 |
Zic family member 1 |
1626 |
0.36 |
chr2_167350846_167351007 | 1.04 |
SCN7A |
sodium channel, voltage-gated, type VII, alpha subunit |
169 |
0.97 |
chr19_57182553_57183430 | 1.04 |
ZNF835 |
zinc finger protein 835 |
137 |
0.95 |
chrX_39964334_39965624 | 1.03 |
BCOR |
BCL6 corepressor |
8323 |
0.32 |
chr9_21964953_21966022 | 1.03 |
C9orf53 |
chromosome 9 open reading frame 53 |
1650 |
0.31 |
chr17_64187141_64188685 | 1.03 |
CEP112 |
centrosomal protein 112kDa |
60 |
0.98 |
chr8_144681294_144681621 | 1.03 |
EEF1D |
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
254 |
0.75 |
chr4_79472640_79473562 | 1.02 |
ANXA3 |
annexin A3 |
20 |
0.99 |
chr2_202928832_202928998 | 1.02 |
AC079354.1 |
uncharacterized protein KIAA2012 |
9063 |
0.16 |
chr12_57522507_57523183 | 1.02 |
STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
38 |
0.64 |
chr1_20915430_20915891 | 1.02 |
CDA |
cytidine deaminase |
219 |
0.93 |
chrX_106898289_106898771 | 1.02 |
PRPS1 |
phosphoribosyl pyrophosphate synthetase 1 |
15942 |
0.22 |
chr11_67168049_67169301 | 1.02 |
PPP1CA |
protein phosphatase 1, catalytic subunit, alpha isozyme |
584 |
0.47 |
chr19_3094656_3095580 | 1.02 |
GNA11 |
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
710 |
0.53 |
chr10_112835970_112837137 | 1.01 |
ADRA2A |
adrenoceptor alpha 2A |
237 |
0.95 |
chr1_201618776_201619150 | 1.01 |
NAV1 |
neuron navigator 1 |
1513 |
0.35 |
chr12_49626686_49627168 | 1.01 |
TUBA1C |
tubulin, alpha 1c |
5218 |
0.14 |
chr16_14280583_14281066 | 1.01 |
MKL2 |
MKL/myocardin-like 2 |
52 |
0.98 |
chr11_121593168_121593875 | 1.01 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
132393 |
0.05 |
chr20_50178264_50178663 | 1.00 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
705 |
0.79 |
chr8_63998343_63998943 | 1.00 |
TTPA |
tocopherol (alpha) transfer protein |
31 |
0.98 |
chr13_102105024_102105412 | 1.00 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
200 |
0.96 |
chr3_48597891_48598569 | 1.00 |
PFKFB4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
332 |
0.77 |
chr15_43810189_43810361 | 1.00 |
MAP1A |
microtubule-associated protein 1A |
452 |
0.77 |
chr9_113341179_113342041 | 0.99 |
SVEP1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
213 |
0.96 |
chr6_125474823_125475949 | 0.99 |
TPD52L1 |
tumor protein D52-like 1 |
51 |
0.99 |
chr11_111781952_111782550 | 0.98 |
CRYAB |
crystallin, alpha B |
289 |
0.7 |
chrX_67913478_67914353 | 0.98 |
STARD8 |
StAR-related lipid transfer (START) domain containing 8 |
422 |
0.91 |
chr4_81189966_81190509 | 0.98 |
FGF5 |
fibroblast growth factor 5 |
2444 |
0.36 |
chr18_6729547_6730123 | 0.98 |
ARHGAP28 |
Rho GTPase activating protein 28 |
14 |
0.5 |
chr1_40598519_40598964 | 0.98 |
RLF |
rearranged L-myc fusion |
28304 |
0.14 |
chr7_1198879_1199732 | 0.98 |
ZFAND2A |
zinc finger, AN1-type domain 2A |
484 |
0.55 |
chrX_67867525_67867904 | 0.98 |
STARD8 |
StAR-related lipid transfer (START) domain containing 8 |
104 |
0.98 |
chr9_117149358_117150269 | 0.97 |
AKNA |
AT-hook transcription factor |
430 |
0.85 |
chr6_73660207_73660427 | 0.97 |
ENSG00000266180 |
. |
17159 |
0.24 |
chr1_148864424_148864911 | 0.97 |
ENSG00000222854 |
. |
48715 |
0.16 |
chr19_16567801_16568854 | 0.97 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
14427 |
0.12 |
chr2_218807050_218807399 | 0.97 |
TNS1 |
tensin 1 |
1569 |
0.44 |
chr1_245329429_245329885 | 0.96 |
KIF26B |
kinesin family member 26B |
11370 |
0.2 |
chr12_10876110_10876483 | 0.96 |
YBX3 |
Y box binding protein 3 |
385 |
0.85 |
chr4_168154960_168155824 | 0.96 |
SPOCK3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
25 |
0.99 |
chr20_6032553_6033205 | 0.96 |
LRRN4 |
leucine rich repeat neuronal 4 |
1816 |
0.35 |
chr5_39422660_39422883 | 0.96 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
2199 |
0.42 |
chr1_184121923_184122452 | 0.96 |
ENSG00000199840 |
. |
18770 |
0.25 |
chr7_117512754_117513170 | 0.96 |
CTTNBP2 |
cortactin binding protein 2 |
599 |
0.85 |
chr1_98515040_98515403 | 0.96 |
ENSG00000225206 |
. |
3494 |
0.38 |
chr13_93879365_93880233 | 0.95 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr15_91500342_91500803 | 0.95 |
RCCD1 |
RCC1 domain containing 1 |
1546 |
0.18 |
chr7_55154157_55154506 | 0.95 |
EGFR |
epidermal growth factor receptor |
23085 |
0.26 |
chr12_63545508_63545951 | 0.95 |
AVPR1A |
arginine vasopressin receptor 1A |
1007 |
0.7 |
chr3_74662850_74663055 | 0.95 |
ENSG00000263689 |
. |
78930 |
0.11 |
chr17_13505362_13505866 | 0.95 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
370 |
0.91 |
chr12_16500618_16501134 | 0.95 |
MGST1 |
microsomal glutathione S-transferase 1 |
145 |
0.97 |
chr8_6691754_6692464 | 0.94 |
DEFB1 |
defensin, beta 1 |
43435 |
0.14 |
chr6_100729238_100729940 | 0.94 |
RP1-121G13.2 |
|
145405 |
0.05 |
chr6_166721057_166722024 | 0.94 |
PRR18 |
proline rich 18 |
331 |
0.9 |
chr12_40618871_40619488 | 0.93 |
LRRK2 |
leucine-rich repeat kinase 2 |
303 |
0.89 |
chr11_22214479_22215097 | 0.93 |
ANO5 |
anoctamin 5 |
66 |
0.98 |
chr9_90588787_90589959 | 0.93 |
CDK20 |
cyclin-dependent kinase 20 |
29 |
0.98 |
chr10_128249841_128250268 | 0.93 |
ENSG00000221717 |
. |
4421 |
0.3 |
chr4_75718841_75720131 | 0.93 |
BTC |
betacellulin |
410 |
0.91 |
chr11_63438034_63439177 | 0.93 |
ATL3 |
atlastin GTPase 3 |
479 |
0.76 |
chr12_6937518_6938631 | 0.92 |
LEPREL2 |
leprecan-like 2 |
502 |
0.55 |
chr16_55542879_55544136 | 0.92 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
597 |
0.77 |
chr10_35098017_35098428 | 0.92 |
PARD3 |
par-3 family cell polarity regulator |
6027 |
0.24 |
chr14_63671002_63671585 | 0.92 |
RHOJ |
ras homolog family member J |
167 |
0.97 |
chr15_89181571_89183025 | 0.92 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
114 |
0.96 |
chr7_152219742_152220164 | 0.91 |
ENSG00000199404 |
. |
70223 |
0.09 |
chr5_149534173_149534381 | 0.91 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
913 |
0.52 |
chr6_150152266_150152469 | 0.91 |
RP11-350J20.12 |
|
21231 |
0.11 |
chr19_14048794_14049313 | 0.91 |
PODNL1 |
podocan-like 1 |
144 |
0.92 |
chr12_58129779_58130334 | 0.91 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
1563 |
0.16 |
chr10_44879737_44880262 | 0.91 |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
492 |
0.84 |
chr17_1665908_1666244 | 0.90 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
47 |
0.96 |
chr7_97952929_97953353 | 0.90 |
RP11-307C18.1 |
|
976 |
0.55 |
chr1_229546515_229546959 | 0.90 |
ENSG00000252051 |
. |
223 |
0.92 |
chr9_140500205_140501463 | 0.90 |
ARRDC1 |
arrestin domain containing 1 |
679 |
0.56 |
chr15_48469342_48470564 | 0.90 |
MYEF2 |
myelin expression factor 2 |
597 |
0.66 |
chr9_13568681_13569117 | 0.90 |
MPDZ |
multiple PDZ domain protein |
289310 |
0.01 |
chr17_21730845_21731525 | 0.89 |
UBBP4 |
ubiquitin B pseudogene 4 |
185 |
0.97 |
chr9_128521797_128522422 | 0.89 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
11631 |
0.27 |
chr4_14864468_14865022 | 0.89 |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
139553 |
0.05 |
chr4_157890038_157890662 | 0.89 |
PDGFC |
platelet derived growth factor C |
1705 |
0.41 |
chr7_82188634_82189045 | 0.89 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
115725 |
0.07 |
chr11_34448298_34448762 | 0.89 |
CAT |
catalase |
11942 |
0.23 |
chr7_97912986_97913801 | 0.89 |
BRI3 |
brain protein I3 |
2406 |
0.26 |
chr17_32583150_32583439 | 0.89 |
AC005549.3 |
Uncharacterized protein |
988 |
0.32 |
chr9_115652611_115653484 | 0.88 |
SLC46A2 |
solute carrier family 46, member 2 |
146 |
0.96 |
chr12_81471441_81472090 | 0.88 |
ACSS3 |
acyl-CoA synthetase short-chain family member 3 |
71 |
0.98 |
chr15_39464989_39465402 | 0.88 |
RP11-624L4.1 |
|
54281 |
0.16 |
chr9_12776574_12776837 | 0.88 |
LURAP1L |
leucine rich adaptor protein 1-like |
1685 |
0.38 |
chr3_42113480_42113939 | 0.88 |
TRAK1 |
trafficking protein, kinesin binding 1 |
18853 |
0.25 |
chr2_96809842_96811219 | 0.88 |
DUSP2 |
dual specificity phosphatase 2 |
649 |
0.65 |
chr15_63336117_63336463 | 0.88 |
TPM1 |
tropomyosin 1 (alpha) |
315 |
0.89 |
chr15_66997154_66997305 | 0.88 |
SMAD6 |
SMAD family member 6 |
2555 |
0.35 |
chr12_3308931_3310293 | 0.88 |
TSPAN9 |
tetraspanin 9 |
729 |
0.75 |
chr10_18629419_18629841 | 0.88 |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
36 |
0.99 |
chr18_53005046_53005364 | 0.88 |
TCF4 |
transcription factor 4 |
14023 |
0.28 |
chr12_120241388_120241613 | 0.88 |
CIT |
citron (rho-interacting, serine/threonine kinase 21) |
313 |
0.92 |
chr8_120428169_120429285 | 0.88 |
NOV |
nephroblastoma overexpressed |
181 |
0.96 |
chr16_14279913_14280368 | 0.87 |
MKL2 |
MKL/myocardin-like 2 |
434 |
0.86 |
chr14_89769991_89770787 | 0.87 |
RP11-356K23.1 |
|
46240 |
0.14 |
chr7_137671468_137671947 | 0.87 |
CREB3L2 |
cAMP responsive element binding protein 3-like 2 |
15086 |
0.19 |
chr15_74221251_74221642 | 0.87 |
LOXL1-AS1 |
LOXL1 antisense RNA 1 |
857 |
0.51 |
chr2_217498507_217499483 | 0.87 |
IGFBP2 |
insulin-like growth factor binding protein 2, 36kDa |
877 |
0.6 |
chr17_27949136_27950218 | 0.86 |
CORO6 |
coronin 6 |
237 |
0.62 |
chr6_56111778_56112295 | 0.86 |
COL21A1 |
collagen, type XXI, alpha 1 |
199 |
0.97 |
chr9_102130860_102131451 | 0.86 |
ENSG00000222337 |
. |
84851 |
0.09 |
chr1_2005099_2005545 | 0.86 |
PRKCZ |
protein kinase C, zeta |
103 |
0.96 |
chr3_192126971_192127690 | 0.86 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chr10_90711644_90712353 | 0.85 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
532 |
0.73 |
chr6_163681477_163682017 | 0.85 |
ENSG00000239136 |
. |
33805 |
0.21 |
chr17_40574611_40575251 | 0.85 |
PTRF |
polymerase I and transcript release factor |
604 |
0.59 |
chr9_129883844_129884128 | 0.85 |
ANGPTL2 |
angiopoietin-like 2 |
927 |
0.66 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
1.2 | 3.6 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.0 | 1.0 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
1.0 | 2.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.9 | 2.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 4.5 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.8 | 3.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.8 | 2.4 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.7 | 1.5 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.7 | 4.5 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.7 | 2.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 2.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.7 | 2.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 2.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.7 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 2.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 2.5 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 1.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.6 | 0.6 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.6 | 1.8 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.6 | 1.7 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.5 | 1.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.5 | 1.1 | GO:0050955 | thermoception(GO:0050955) |
0.5 | 1.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.5 | 1.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 1.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.5 | 2.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 1.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 3.1 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.5 | 3.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 1.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.5 | 1.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.5 | 1.5 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.5 | 2.3 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.5 | 0.9 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.5 | 2.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.5 | 1.4 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 1.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 3.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 0.9 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.4 | 0.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 4.9 | GO:0048844 | artery morphogenesis(GO:0048844) artery development(GO:0060840) |
0.4 | 0.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 2.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 0.4 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.4 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 1.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.7 | GO:0060013 | righting reflex(GO:0060013) |
0.4 | 0.8 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.4 | 2.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 0.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.4 | 1.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 0.8 | GO:0060242 | contact inhibition(GO:0060242) |
0.4 | 0.4 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.4 | 1.2 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.4 | 2.7 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.4 | 1.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 2.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.4 | 6.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 1.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.4 | 3.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.4 | 1.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.4 | 0.4 | GO:1903670 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.4 | 0.8 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.4 | 1.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 2.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.4 | 2.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.4 | 1.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.4 | 0.4 | GO:0060435 | bronchiole development(GO:0060435) |
0.4 | 1.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 0.4 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.4 | 1.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 1.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 1.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 0.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 1.0 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.3 | 2.7 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.3 | 1.0 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.3 | 1.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.7 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.3 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.3 | 0.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.3 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.3 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.9 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.3 | 0.3 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 0.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 0.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 0.9 | GO:0071883 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 | 0.9 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.3 | 0.6 | GO:0001714 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.3 | 0.9 | GO:0022605 | oogenesis stage(GO:0022605) |
0.3 | 0.6 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.3 | 0.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.6 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.3 | 3.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.3 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.6 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.3 | 2.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.3 | 1.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 2.0 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 0.6 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 1.1 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.6 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.3 | 0.5 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 1.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 1.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 1.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 0.8 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.3 | 0.5 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.3 | 1.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.3 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 0.8 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.3 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 0.8 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.5 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.3 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 6.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.2 | 1.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.2 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.2 | 3.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 1.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 1.7 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 1.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.9 | GO:0090102 | cochlea development(GO:0090102) |
0.2 | 0.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.9 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.9 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.2 | 0.5 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.2 | 0.4 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.2 | 0.7 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.2 | 0.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 1.1 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.2 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 1.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 1.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.2 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.2 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.7 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.2 | 1.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 1.5 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 0.6 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 0.8 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.4 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.2 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 1.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.4 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.2 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.2 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 1.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 2.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 1.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.2 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.2 | 0.8 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.2 | GO:0060433 | bronchus development(GO:0060433) |
0.2 | 0.6 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 0.4 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 1.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 1.0 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.8 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 1.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.2 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.2 | 0.6 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.2 | 1.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.2 | 1.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.9 | GO:0032288 | myelin assembly(GO:0032288) |
0.2 | 0.9 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 2.0 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.2 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.2 | 1.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.7 | GO:0070091 | glucagon secretion(GO:0070091) |
0.2 | 0.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.8 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 0.5 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.5 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.7 | GO:0060039 | pericardium development(GO:0060039) |
0.2 | 2.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 0.7 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.2 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.2 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.2 | GO:0072070 | loop of Henle development(GO:0072070) |
0.2 | 0.5 | GO:0060219 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.3 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.2 | 1.2 | GO:0090398 | cellular senescence(GO:0090398) |
0.2 | 1.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 0.3 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.2 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 1.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 0.6 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.2 | 1.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.9 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.5 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.2 | 0.9 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 2.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 1.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.9 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.4 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.1 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.7 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.7 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.4 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 1.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.6 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.1 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.1 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.1 | 0.1 | GO:0072177 | nephric duct development(GO:0072176) mesonephric duct development(GO:0072177) nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.8 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.8 | GO:0015904 | tetracycline transport(GO:0015904) |
0.1 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 1.3 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.3 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.4 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 1.2 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 1.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.3 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.1 | 0.6 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.7 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.6 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.4 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.1 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.4 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.1 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.6 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.1 | 1.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 2.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.7 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.6 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.1 | 0.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 4.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.4 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 1.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.1 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 0.4 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 2.0 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 1.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.1 | 0.6 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.5 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 1.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.2 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 2.0 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 0.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.3 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.6 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.5 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) metanephric renal vesicle morphogenesis(GO:0072283) |
0.1 | 1.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.8 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.3 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.7 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 1.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 1.3 | GO:0097480 | synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
0.1 | 0.1 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.3 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.7 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.1 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.1 | 0.8 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.3 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.4 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.1 | 0.2 | GO:0048820 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.2 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 0.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.9 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.2 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 2.1 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 1.2 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 1.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.6 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 7.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.5 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.5 | GO:0061647 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.1 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 2.1 | GO:0071773 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 1.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.4 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.1 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.1 | 0.4 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0052509 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0001508 | action potential(GO:0001508) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.5 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.2 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 0.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.8 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 6.1 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.8 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.1 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.3 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.4 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.8 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.3 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.4 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.5 | GO:1990138 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.4 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.1 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0006110 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of nucleotide catabolic process(GO:0030811) regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) regulation of ATP metabolic process(GO:1903578) |
0.0 | 0.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 1.2 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0031649 | heat generation(GO:0031649) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.2 | GO:0042551 | neuron maturation(GO:0042551) |
0.0 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.3 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 1.2 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.2 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.3 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.0 | 0.1 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) endochondral bone morphogenesis(GO:0060350) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.1 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.3 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.3 | GO:0030324 | lung development(GO:0030324) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.0 | GO:0010574 | vascular endothelial growth factor production(GO:0010573) regulation of vascular endothelial growth factor production(GO:0010574) |
0.0 | 0.3 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.0 | 0.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.0 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.0 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.1 | GO:0006900 | membrane budding(GO:0006900) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.0 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0070852 | cell body fiber(GO:0070852) |
1.1 | 3.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.8 | 3.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.8 | 4.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 3.7 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 4.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 1.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.5 | 2.5 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 0.5 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.4 | 4.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 3.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.4 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.4 | 1.4 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 2.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 2.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 0.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.3 | 1.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 0.3 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.3 | 5.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 1.1 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 2.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 0.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 2.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 2.2 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.2 | 2.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.2 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.2 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.8 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.8 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 5.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 0.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 43.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 1.1 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 4.6 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 2.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.4 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 6.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 1.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 7.3 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.6 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 2.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.5 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 8.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 7.2 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.8 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 2.0 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 2.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 7.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.6 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.8 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 29.6 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 2.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 2.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 10.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 3.1 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.0 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 3.0 | GO:0098794 | postsynapse(GO:0098794) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 1.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 2.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.2 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.4 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.3 | GO:0036064 | ciliary basal body(GO:0036064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.3 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
1.4 | 4.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.9 | 2.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.9 | 2.7 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.9 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 2.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 1.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 3.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 1.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 1.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 1.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.5 | 1.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 2.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 2.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.5 | 3.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 1.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 2.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 2.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 2.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 1.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 1.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 2.5 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.4 | 1.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.4 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 1.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 2.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.4 | 1.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 3.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.5 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 2.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 1.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 3.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 2.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 3.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.3 | 1.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 1.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 1.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.3 | 1.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 7.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 2.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.3 | 1.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 1.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 0.9 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.3 | 0.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 10.7 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 1.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.3 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 0.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 16.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 1.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 2.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 4.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 0.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.0 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 1.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.7 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 1.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 1.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 4.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 1.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 0.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 1.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 2.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 2.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 2.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.2 | 0.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 1.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.4 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 4.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 1.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 2.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 2.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 2.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 6.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.8 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.2 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 2.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.8 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 2.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 1.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 2.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 2.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.7 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.1 | 0.5 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 5.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.1 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 2.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 1.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.8 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.7 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 1.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.3 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 2.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 1.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 1.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 9.1 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.5 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 1.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 7.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.1 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 1.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.4 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.7 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 3.1 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 2.3 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 2.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 2.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 9.7 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.5 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 2.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.4 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.0 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.0 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 5.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 15.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 2.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 9.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 9.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 38.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 3.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 7.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 4.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 25.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 7.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 7.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.5 | 4.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 1.3 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.4 | 3.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 8.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 10.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 16.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 2.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 2.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 1.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 4.3 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 2.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 1.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 1.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 3.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.7 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 4.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 3.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 3.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 2.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 1.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 1.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 2.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.6 | REACTOME DEFENSINS | Genes involved in Defensins |